TrialJournal of the European Academy of Dermatology and Venereology : JEADV2017

Positive impact of omalizumab on angioedema and quality of life in patients with refractory chronic idiopathic/spontaneous urticaria: analyses according to the presence or absence of angioedema.

M Maurer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.